Volume 41, Number 12, 2477-2481, DOI: 10.1007/BF02100146

Published in partnership with the

Logo

Gastroenterology Research Group

Antagonistic effects of sulfide and butyrate on proliferation of colonic mucosa
A potential role for these agents in the pathogenesis of ulcerative colitis

Stefan U. Christl, Hans-Dieter Eisner, Gerda Dusel, Heinrich Kasper and Wolfgang Scheppach

View Related Documents

Abstract

It has been shown that feces of patients with ulcerative colitis uniformly contain sulfate reducing bacteria. Sulfide produced by these bacteria interferes with butyrate-dependent energy metabolism of cultured colonocytes and may be involved in the pathogenesis of ulcerative colitis. Mucosal biopsies from the sigmoid rectum of 10 patients (no caner, polyps, inflammatory bowel disease) were incubated with either NaCl, sodium hydrogen sulfide (1 mmol/L), a combination of both sodium hydrogen sulfide and butyrate (10 mmol/L), or butyrate. Mucosal proliferation was assessed by bromodeoxyuridine labeling of cells in S-phase. Compared to NaCl, sulfide increased the labeling of the entire crypt significantly, by 19% (p < 0.05).="" this="" effect="" was="" due="" to="" an="" expansion="" of="" the="" proliferative="" zone="" to="" the="" upper="" crypt="" (compartments="" 3–5),="" where="" the="" increase="" in="" proliferation="" was="" 54%.="" sulfide-induced="" hyperproliferation="" was="" reversed="" when="" samples="" were="" coincubated="" with="" sulfide="" and="" butyrate.="" the="" study="" shows="" that="" sodium="" hydrogen="" sulfide="" induces="" mucosal="" hyperproliferation.="" our="" data="" support="" a="" possible="" role="" of="" sulfide="" in="" the="" pathogenesis="" of="" uc="" and="" confirm="" the="" role="" of="" butyrate="" in="" the="" regulation="" of="" colonic="" proliferation="" and="" in="" the="" treatment="" of="">

Key words  ulcerative colitis - sulfide - sulfate reduction - butyrate - proliferation

Fulltext Preview

Image of the first page of the fulltext document